Pfizer Invites Public to Register for Webcast of Analyst and Investor Call to Discuss Pfizer-BioNTech COVID-19 Vaccine and Pfizer’s Novel COVID-19 Oral Antiviral Treatment Candidate
December 07 2021 - 10:00AM
Business Wire
Pfizer Inc. (NYSE: PFE) invites investors and the general public
to access a live webcast of a presentation and conference call with
investment analysts at 8:30 a.m. EST on Friday, December 17, 2021.
Pfizer Vaccines and Hospital leadership will discuss the
Pfizer-BioNTech COVID-19 vaccine and Pfizer’s novel COVID-19 oral
antiviral treatment candidate.
To access the webcast and presentation slides, visit our web
site at www.pfizer.com/investors. Information on accessing and
registering for the webcast will be available at
www.pfizer.com/investors beginning today. Participants are advised
to register in advance.
Participants will also have an opportunity to ask questions in a
live Q&A session with leadership. Those participants who would
like to ask a question can dial either (833) 708-1779 in the United
States and Canada or (602) 585-9859 outside of the United States
and Canada. The passcode is “121621”.
The transcript and webcast replay will be made available on our
web site at www.pfizer.com/investors within 24 hours after the end
of the live webcast and will be accessible for at least 90
days.
About Pfizer: Breakthroughs That Change Patients’ Lives
At Pfizer, we apply science and our global resources to bring
therapies to people that extend and significantly improve their
lives. We strive to set the standard for quality, safety and value
in the discovery, development and manufacture of health care
products, including innovative medicines and vaccines. Every day,
Pfizer colleagues work across developed and emerging markets to
advance wellness, prevention, treatments and cures that challenge
the most feared diseases of our time. Consistent with our
responsibility as one of the world's premier innovative
biopharmaceutical companies, we collaborate with health care
providers, governments and local communities to support and expand
access to reliable, affordable health care around the world. For
more than 170 years, we have worked to make a difference for all
who rely on us. We routinely post information that may be important
to investors on our website at www.Pfizer.com. In addition, to
learn more, please visit us on www.Pfizer.com and follow us on
Twitter at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us
on Facebook at Facebook.com/Pfizer.
Disclosure Notice: The webcast may include
forward-looking statements about, among other things, our efforts
to respond to COVID-19, including our development of a vaccine to
help prevent COVID-19 and our investigational protease inhibitors,
our anticipated operating and financial performance,
reorganizations, business plans and prospects; expectations for our
product pipeline, in-line products and product candidates,
including anticipated regulatory submissions, data read-outs, study
starts, approvals, clinical trial results and other developing
data, revenue contribution, growth, performance, timing of
exclusivity and potential benefits; and manufacturing and product
supply, that are subject to substantial risks and uncertainties
that could cause actual results to differ materially from those
expressed or implied by such statements. A description of these
risks and uncertainties can be found in Pfizer’s Annual Report on
Form 10-K for the fiscal year ended December 31, 2020 and in its
subsequent reports on Form 10-Q, including in the sections thereof
captioned “Risk Factors” and “Forward-Looking Information and
Factors That May Affect Future Results”, as well as in its
subsequent reports on Form 8-K, all of which are filed with the
U.S. Securities and Exchange Commission and available at
www.sec.gov and www.pfizer.com.
The forward-looking statements in the webcast speak only as of
the original date of the webcast. Pfizer assumes no obligation to
update forward-looking statements contained in the webcast as the
result of new information or future events or developments.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211207005083/en/
Media Contact:
PfizerMediaRelations@Pfizer.com
+1 (212) 733-1226
Investor Contact:
IR@Pfizer.com +1 (212) 733-4848
Pfizer (NYSE:PFE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Pfizer (NYSE:PFE)
Historical Stock Chart
From Apr 2023 to Apr 2024